VivoSeq
Psychiatry

Alcohol Use

0

Pipeline Programs

3

Active Trials

0

Companies Involved

Alcohol Use is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

6/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

18

clinical trials

Completed13 · 72%
Not yet recruiting3 · 17%
Unknown status1 · 6%
Terminated1 · 6%

Trial Activity

18 trials

Addressing Heavy Alcohol Use Consumption With Kudzu
Completed··Phase 2·NCT03709043·120 enrolled
High Dose Vitamin B1 to Reduce Abusive Alcohol Use
Completed·UUniversity of Kansas·Phase 4·NCT00680121·120 enrolled
The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects
Completed··Phase 4·NCT00329407·10 enrolled
Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms
Completed··Phase 1/2·NCT01641445·82 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)